SLC34A2 and non-small cell lung carcinoma: Given that miR-410 directly targeted SLC34A2 and inhibition of miR-410 prohibited the Wnt/β-catenin pathway, we next tested whether SLC34A2 interference could rescue the inhibition of Wnt/β-catenin pathway by miR-410 interference in NSCLC cells.